185 related articles for article (PubMed ID: 35239032)
1. Furosemide and albumin for the treatment of nephrotic edema: a systematic review.
Hedin E; Bijelić V; Barrowman N; Geier P
Pediatr Nephrol; 2022 Aug; 37(8):1747-1757. PubMed ID: 35239032
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Human albumin infusion for treating oedema in people with nephrotic syndrome.
Ho JJ; Adnan AS; Kueh YC; Ambak NJ; Van Rostenberghe H; Jummaat F
Cochrane Database Syst Rev; 2019 Jul; 7(7):CD009692. PubMed ID: 31425606
[TBL] [Abstract][Full Text] [Related]
4. Co-administration of albumin-furosemide in patients with the nephrotic syndrome.
Ghafari A; Mehdizadeh A; Alavi-Darazam I; Rahimi E; Kargar C; Sepehrvand N
Saudi J Kidney Dis Transpl; 2011 May; 22(3):471-5. PubMed ID: 21566302
[TBL] [Abstract][Full Text] [Related]
5. Treatment of severe edema in children with nephrotic syndrome with diuretics alone--a prospective study.
Kapur G; Valentini RP; Imam AA; Mattoo TK
Clin J Am Soc Nephrol; 2009 May; 4(5):907-13. PubMed ID: 19406963
[TBL] [Abstract][Full Text] [Related]
6. Diuretic effect of co-administration of furosemide and albumin in comparison to furosemide therapy alone: An updated systematic review and meta-analysis.
Lee TH; Kuo G; Chang CH; Huang YT; Yen CL; Lee CC; Fan PC; Chen JJ
PLoS One; 2021; 16(12):e0260312. PubMed ID: 34851962
[TBL] [Abstract][Full Text] [Related]
7. Combined furosemide and human albumin treatment for diuretic-resistant edema.
Elwell RJ; Spencer AP; Eisele G
Ann Pharmacother; 2003 May; 37(5):695-700. PubMed ID: 12708949
[TBL] [Abstract][Full Text] [Related]
8. Interventions for minimal change disease in adults with nephrotic syndrome.
Azukaitis K; Palmer SC; Strippoli GF; Hodson EM
Cochrane Database Syst Rev; 2022 Mar; 3(3):CD001537. PubMed ID: 35230699
[TBL] [Abstract][Full Text] [Related]
9. Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
Liu ID; Willis NS; Craig JC; Hodson EM
Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31749142
[TBL] [Abstract][Full Text] [Related]
10. The added-up albumin enhances the diuretic effect of furosemide in patients with hypoalbuminemic chronic kidney disease: a randomized controlled study.
Phakdeekitcharoen B; Boonyawat K
BMC Nephrol; 2012 Aug; 13():92. PubMed ID: 22931630
[TBL] [Abstract][Full Text] [Related]
11. Lipid-lowering agents for nephrotic syndrome.
Kong X; Yuan H; Fan J; Li Z; Wu T; Jiang L
Cochrane Database Syst Rev; 2013 Dec; (12):CD005425. PubMed ID: 24327265
[TBL] [Abstract][Full Text] [Related]
12. Chinese herbal medicine Huangqi type formulations for nephrotic syndrome.
Feng M; Yuan W; Zhang R; Fu P; Wu T
Cochrane Database Syst Rev; 2013 Jun; (6):CD006335. PubMed ID: 23740567
[TBL] [Abstract][Full Text] [Related]
13. Current Perspectives in Management of Edema in Nephrotic Syndrome.
Meena J; Bagga A
Indian J Pediatr; 2020 Aug; 87(8):633-640. PubMed ID: 32232733
[TBL] [Abstract][Full Text] [Related]
14. Interventions for focal segmental glomerulosclerosis in adults.
Hodson EM; Sinha A; Cooper TE
Cochrane Database Syst Rev; 2022 Feb; 2(2):CD003233. PubMed ID: 35224732
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and Safety of Combination Therapy with Tolvaptan and Furosemide in Children with Nephrotic Syndrome and Refractory Edema: A Prospective Interventional Study.
Meena J; Hari P; Sinha A; Bagga A
Indian J Pediatr; 2022 Jul; 89(7):699-705. PubMed ID: 35080742
[TBL] [Abstract][Full Text] [Related]
16. Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
von Groote TC; Williams G; Au EH; Chen Y; Mathew AT; Hodson EM; Tunnicliffe DJ
Cochrane Database Syst Rev; 2021 Nov; 11(11):CD004293. PubMed ID: 34778952
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of furosemide-albumin compared with furosemide in critically ill hypoalbuminemia patients admitted to intensive care unit: a prospective randomized clinical trial.
Mahmoodpoor A; Zahedi S; Pourakbar A; Hamishehkar H; Shadvar K; Asgharian P; Shahabi F; Hamishehkar H
Daru; 2020 Jun; 28(1):263-269. PubMed ID: 32291620
[TBL] [Abstract][Full Text] [Related]
18. Autologous serum eye drops for dry eye.
Pan Q; Angelina A; Marrone M; Stark WJ; Akpek EK
Cochrane Database Syst Rev; 2017 Feb; 2(2):CD009327. PubMed ID: 28245347
[TBL] [Abstract][Full Text] [Related]
19. Aldosterone antagonists in addition to renin angiotensin system antagonists for preventing the progression of chronic kidney disease.
Chung EY; Ruospo M; Natale P; Bolignano D; Navaneethan SD; Palmer SC; Strippoli GF
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD007004. PubMed ID: 33107592
[TBL] [Abstract][Full Text] [Related]
20. Immunosuppressive agents for treating IgA nephropathy.
Natale P; Palmer SC; Ruospo M; Saglimbene VM; Craig JC; Vecchio M; Samuels JA; Molony DA; Schena FP; Strippoli GF
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD003965. PubMed ID: 32162319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
